CD90 Antibody
Ref. 3D-10-2979
| 20µg | 735,00 € | ||
| 50µg | 1.008,00 € | ||
| 100µg | 1.248,00 € |
Información del producto
The CD90 Antibody is a highly effective anti-HER2 antibody that targets the growth factor receptor HER2. It is commonly used in combination with other therapies, such as trastuzumab, to treat HER2-positive breast cancer. This monoclonal antibody specifically binds to HER2 receptors, inhibiting their activation and preventing the growth and spread of cancer cells.
In addition to its anti-cancer properties, the CD90 Antibody has also been shown to have immunomodulatory effects. It can stimulate the production of interleukin-6 (IL-6), a cytokine involved in immune response regulation. This stimulation of IL-6 production can enhance the immune system's ability to fight against cancer cells.
Furthermore, the CD90 Antibody has been found to have multidrug resistance reversal activity. It can inhibit the efflux pumps responsible for drug resistance in cancer cells, making them more susceptible to chemotherapy treatments.
The CD90 Antibody is a valuable tool in Life Sciences research
Propiedades químicas
Consulta técnica sobre: 3D-10-2979 CD90 Antibody
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
